Sort   by:  
 Page size 
UnknownGenetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.
Not available
S-EPMC3431328 | biostudies-literature
UnknownCommon variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Not available
S-EPMC4154629 | biostudies-literature
UnknownCirculating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.
Not available
S-EPMC4158711 | biostudies-literature
UnknownEffects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Not available
S-EPMC3439414 | biostudies-literature
UnknownTCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program.
Not available
S-EPMC3144193 | biostudies-literature
UnknownExtension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
Not available
S-EPMC2518503 | biostudies-literature
UnknownThe Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures.
Not available
S-EPMC7783946 | biostudies-literature
UnknownGenome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Not available
S-EPMC10790310 | biostudies-literature
UnknownThe 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS).
Not available
S-EPMC9494851 | biostudies-literature
UnknownAssociation of Metformin With the Development of Age-Related Macular Degeneration.
Not available
S-EPMC9936345 | biostudies-literature
Sort   by:  
 Page size